Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZTS vs MRNA✓SelectedUSD · MRNAZTS vs MRNA performance historyLatest closeAs of+2.50%11/18
Stock and ETF performance explorer

ZTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5.2%
MRNA return
+794.5%
Excess return
-789.3%
Maximum drawdown
-70.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+2.5%-4.8%+7.3%+2.7%
7D+3.6%-20.9%+24.5%+4.7%
30D+8.2%-13.3%+21.5%+8.8%
3M+16.5%+212.6%-196.1%+6.4%
6M+11.6%+309.0%-297.4%-0.4%
YTD-30.5%+567.3%-597.8%-40.3%
1Y-25.9%+689.7%-715.6%-37.3%
3Y-48.8%+157.4%-206.2%-54.4%
5Y-59.6%-21.7%-37.9%-62.6%
All+5.2%+794.5%-789.3%-13.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling